Saturday links: optimizing for the bots
Tadas Viskanta
Abnormal Returns
18 hours ago
4 MIN READ
Autos
- Why American cars can’t have normal headlights. (theatlantic.com)
- China’s EV adoption rate is soaring. (sherwood.news)
- The Rivian ($RIVN) R2 is here. (cnbc.com)
Transport
- Protected bike lanes give a big boost to riding. (phys.org)
- How driverless trucks are doing in practice. (wsj.com)
- How drones can help fight wildfires. (godspeed.today)
- What problem(s) air taxis solve. (notboring.co)
Environment
- The Trump administration is pulling the plug on the Ocean Observatories Initiative. (thebulwark.com)
- Amazon deforestation hits lowest level since 2019. (semafor.com)
- Measuring the costs of the drying up of the Great Salt Lake. (papers.ssrn.com)
- Weather can’t be avoided, it can only be priced. (unstableequilibria.substack.com)
Animals
Science
- The Trump administration wants to defund social science research. (theatlantic.com)
- Centralizing decision making is a disaster for American science. (marginalrevolution.com)
- The Trump administration is doing everything it can to dismantle science programs. (bloomberg.com)
- Will AI kill the academic research paper format? (marginalrevolution.com)
Apple
- The iPhone is still central to what Apple ($AAPL) does. (stratechery.com)
- Apple ($AAPL) is making the iPhone an AI device. (spyglass.org)
- The new Siri just needs to work. (spyglass.org)
Technology
- We are beginning to sort through where AI models make the most sense. (spyglass.org)
- Why aren’t there American open source AI models? (cloudedjudgement.substack.com)
- Dwarkesh Patel talks with Alex Imas and Phil Trammel about the economics of AI. (youtube.com)
- Five things you need to know about AI. (technologyreview.com)
- ChatGPT has not killed Google Search. (sherwood.news)
- OpenAI has filed to go public. (wsj.com)
Cancer
- More people are surviving cancer. That doesn’t mean they are in the clear. (npr.org)
- How CRISPR can be used to destroy cancer cells. (innovativegenomics.org)
- GLP-1 use may reduce the incidence of breast cancer. (sciencedaily.com)
Health
- The American College of Obstetricians & Gynecologists has released its own recommendations for maternal vaccination, (arstechnica.com)
- The U.S. is finally getting a new (better) sunscreen ingredient. (marginalrevolution.com)
- A look at recent pharmaceutical breakthroughs. (worksinprogress.news)
- Can we turn back the clock on human cells? (nature.com)
- A reminder that measles is no joke. (wired.com)
- How doctors are using AI. (nytimes.com)
Fitness
- Wearables data is nearing the clinic. (statnews.com)
- Comparing Whoop, Oura, Fitbit and Apple Watch. (wsj.com)
- Left to our own devices we tend to veer left when talking. (nytimes.com)
Drink
- New federal guidelines are out of sync with the research on the harms of alcohol consumption. (statnews.com)
- How brewers filter beer. (slate.com)
Sports
- On the marriage between Trump and UFC. (axios.com)
- The story of the turf World Cup games are getting played on. (theatlantic.com)
- Despite poor performance on the pitch, the U.S. increasingly drives world football. (ft.com)
- Professionalized youth sports is displacing places for kids to play for free. (bloomberg.com)
College
- Eight predictions for the future of colleges including ‘The prestige of the truly elite colleges will, sadly, not change all that much.’ (newyorker.com)
- Keep your syllabi up to date! (papers.ssrn.com)
- What is an AI degree worth? (nytimes.com)
Earlier on Abnormal Returns
- Radical uncertainty and global demographic decline. (abnormalreturns.com)
- Longform links: the decline of books. (abnormalreturns.com)
- Personal finance links: a proven failure. (abnormalreturns.com)
- Research links: setting strategic goals. (abnormalreturns.com)
- Adviser links: what truly matters. (abnormalreturns.com)
- Don’t miss a thing! Sign up for our daily e-mail newsletter. (abnormalreturns.com)
Mixed media
Terms and Conditions
This content, which contains security-related opinions and/or information, is provided for informational purposes only and should not be relied upon in any manner as professional advice, or an endorsement of any practices, products or services. There can be no guarantees or assurances that the views expressed here will be applicable for any particular facts or circumstances, and should not be relied upon in any manner. You should consult your own advisers as to legal, business, tax, and other related matters concerning any investment.
The commentary in this “post” (including any related blog, podcasts, videos, and social media) reflects the personal opinions, viewpoints, and analyses of the Ritholtz Wealth Management employees providing such comments, and should not be regarded the views of Ritholtz Wealth Management LLC. or its respective affiliates or as a description of advisory services provided by Ritholtz Wealth Management or performance returns of any Ritholtz Wealth Management Investments client.
References to any securities or digital assets, or performance data, are for illustrative purposes only and do not constitute an investment recommendation or offer to provide investment advisory services. Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others.
Please see disclosures here.
